DACTraks Debuts for Sponsor to Site Insight
DAC Patient Recruitment Services has rolled out DACTracks, a proprietary clinical trial metrics technology.
DAC Patient Recruitment Services has rolled out DACTracks, a proprietary clinical trial metrics technology. DACTracks offers sponsors online access to reports on their research sites' screening, referrals, randomizations, enrollment, attrition and more. Graphs and charts are a part of the reporting tool, which also offers insight into retention and subject activity, as well as web page analytics.
You can read the full release here.
Semaglutide Significantly Improves Steatohepatitis, Fibrosis in Phase III MASH Trial
May 2nd 2025Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly semaglutide improved liver histology, metabolic markers, and weight loss in patients with biopsy-confirmed metabolic dysfunction–associated steatohepatitis and stage 2 or 3 fibrosis.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
